Formulation and Delivery - Chemical - Biopharmaceutics

(T0930-07-38) Dissolution Bioequivalence Safe Space Assessment of Molnupiravir and NHC Using Physiologically Based Biopharmaceutics Modeling

(W1030-03-14) Development of a Low-Volume In Vitro Dissolution Method for Assessing Variability in Fine Particle Doses of Dry Powder Inhalers

(T1030-03-14) Investigation of Phenoxyethanol Permeation Using the Skin Parallel Artificial Membrane Permeability Assay (PAMPA) Membrane and Mammalian Skin: Correlation and Rank Order

(M1030-03-15) Predicting the Pharmacokinetics of Amorphous Dispersions Using Canine PBPK Models

(M1030-04-20) Amorphous Solid Dispersions for Enhancement of Equilibrium Aqueous Solubility of Sulfamethoxazole

(T1130-01-02) In Vitro Digestion-Diffusion Model for Predicting In Vivo Performance of Lipid-Based Formulations

(W1130-01-02) Study of Etamsylate Release Kinetics from Controlled Release Matrix Tablets Using the Buffer Transition In Vitro Dissolution Method

(M1130-01-05) Evaluating Influence of Critical Quality Attributes of Metronidazole Topical Gel on Bioequivalence Using the Dermal Virtual Bioequivalence (VBE) Module in Simcyp Simulator

(M1130-12-68) Hydroalcoholic Media Effects on Ibuprofen Release from Low Acyl Gellan Gum

(T1230-03-14) Regional Bile Salt and Lipid Concentrations in the Rat Small Intestine: A Comparison between the Lumen and the Mucus Layer

(M1230-04-20) Development of an In Vitro Release Method for Mechlorethamine Hydrochloride Topical Gel

(T1330-01-02) Application of Bottom-Up Absorption Model for Biopharmaceutics Risk Assessment of Preclinical Candidate

(M1330-03-14) Apparent Danazol and Ketoconazole Solubility in the Upper Gastrointestinal Lumen after Administration of a Standard High-Calorie, High-Fat Meal and Its Estimation Using Biorelevant Media

(M1330-12-68) Establishing In Vitro-In Vivo Correlation of Amorphous Solid Dispersions

(M1430-01-02) Impact of Changes in Ophthalmic Emulsion Globule Size Distribution and Viscosity on Tear Film Thickness and Menisci Characteristics

(T1430-03-14) In Vitro Permeation Studies Combined with Microdialysis Sampling Allow Mechanistic Insights into the Dynamic Dissolution-/ Bioconversion-/ Permeation-Behavior of the Prodrug Fosamprenavir

(T1530-01-02) Biopharmaceutical Modeling of Food Effect – Exploring a Role for Dietary Fat

(M1530-03-14) A New Modelling Framework for pH-Sensitive Solid Dispersions Release and Dissolution